We referenced standard quality components (i.e., Senior Management Responsibility, Resource
Management, Document Control, Process Improvement, and System Evaluation) and adapted
them to include only those elements most meaningful for assessing the design of various FDAspecific
processes. From our evaluation of Quality Management (QM) processes, we derived
the following specific recommendations: